Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years gan Monika Engelhardt, Gabriele Ihorst, Ola Landgren, Milena Pantic, Heike Reinhardt, Johannes Waldschmidt, Annette M. May, Martin Schumacher, Martina Kleber, Ralph Wäsch

Cael y testun llawn

Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer gan Andreas R. Thomsen, Andreas R. Thomsen, Jörg Sahlmann, Peter Bronsert, Peter Bronsert, Oliver Schilling, Oliver Schilling, Felicia Poensgen, Felicia Poensgen, Annette M. May, Annette M. May, Sylvia Timme-Bronsert, Sylvia Timme-Bronsert, Anca-Ligia Grosu, Anca-Ligia Grosu, Peter Vaupel, Peter Vaupel, Jan-Olaf Gebbers, Gabriele Multhoff, Anne-Marie Lüchtenborg, Anne-Marie Lüchtenborg

Cael y testun llawn

Activity of decitabine combined with all-<i>trans</i> retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER) gan Christoph Rummelt, Olga Grishina, Claudia Schmoor, Martina Crysandt, Michael Heuser, Katharina S. Götze, Richard F. Schlenk, Konstanze Döhner, Helmut R. Salih, Gerhard Heil, Carsten Müller-Tidow, Wolfram Brugger, Andrea Kündgen, Maike de Wit, Aristoteles Giagounidis, Sebastian Scholl, Andreas Neubauer, Jürgen Krauter, Gesine Bug, Haifa Kathrin Al-Ali, Ralph Wäsch, Heiko Becker, Annette M. May, Justus Duyster, Björn Hackanson, Arnold Ganser, Hartmut Döhner, Michael Lübbert

Cael y testun llawn